Iridex (IRIX) Liabilities and Shareholders Equity (2011 - 2026)

Iridex's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $28.3 million for Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 17.41% year-over-year to $28.3 million in Q2 2026; TTM through Apr 2026 was $117.4 million, a 5.94% decrease from a year earlier, with the FY2026 full-year figure at $29.2 million, changed 0.05% from the prior year.
• Liabilities and Shareholders Equity retreated to $28.3 million in Q2 2026 per IRIX's latest filing, from $29.2 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $48.7 million in Q1 2022 and bottomed at $28.3 million in Q2 2026.
• The 5-year median for Liabilities and Shareholders Equity is $34.3 million (2023), against an average of $36.3 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 74.07% in 2022 and declined 22.26% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $42.3 million in 2022, then dropped by 18.57% to $34.4 million in 2023, then declined by 15.39% to $29.1 million in 2024, then slipped by 2.68% to $28.4 million in 2025, then retreated by 0.28% to $28.3 million in 2026.
• Per Business Quant, the three latest IRIX Liabilities and Shareholders Equity figures stand at $28.3 million (Q2 2026), $29.2 million (Q1 2026), and $28.4 million (Q3 2025).